Shares of CRISPR Therapeutics (NASDAQ: CRSP) gained 3% in mid-day trading Tuesday after the company amended their collaboration agreement with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE